Neuroinflammation at the Grey-White Matter Interface in Active-Duty United States Special Operations Forces

Brian L Edlow,Chieh-En J Tseng,Natalie Gilmore,Isabella R McKinney,Samantha L Tromly,Katryna B Deary,Collin G Hu,Brian C Healy,Christine L Mac Donald,Kristen Dams-O'Connor,Douglas N Greve,Yelena G Bodien,Daniel P Perl,Jacob M Hooker,Nicole R Zürcher

DOI: https://doi.org/10.1101/2024.05.13.24307070

2024-05-14

Abstract:Emerging evidence from autopsy studies indicates that interface astroglial scarring (IAS) at the grey-white matter junction is a pathological signature of repeated blast brain injury in military personnel. However, there is currently no neuroimaging test that detects IAS, which is a major barrier to diagnosis, prevention, and treatment. In 27 active-duty United States Special Operations Forces personnel with high levels of cumulative blast exposure, we performed translocator protein (TSPO) positron emission tomography (PET) using [11C]PBR28 to detect neuroinflammation at the cortical grey-white matter interface, a neuroanatomic location where IAS has been reported in autopsy studies. TSPO signal in individual Operators was compared to the mean TSPO signal in a control group of 9 healthy civilian volunteers. We identified five Operators with TSPO signal at the cortical grey-white matter interface that was more than two standard deviations above the control mean. Cumulative blast exposure, as measured by the Generalized Blast Exposure Value, did not differ between the five Operators with elevated TSPO signal and the 22 Operators without elevated TSPO signal. While the pathophysiologic link between neuroinflammation and IAS remains uncertain, these observations provide the basis for further investigation into TSPO PET as a potential biomarker of repeated blast brain injury.

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to develop a neuroimaging test method capable of detecting the interface astrocytic scar (IAS) at the gray - white matter junction. Specifically, the research aims to detect neuroinflammation in active - duty members of the U.S. Special Operations Forces caused by repeated blast exposures through the use of translocator protein (TSPO) positron - emission tomography (PET), thereby providing potential biomarkers for the diagnosis, prevention, and treatment of repeated blast - induced brain injury (rBBI).

### Specific description of the main problem:

1. **Lack of effective diagnostic tools**:
- Currently, there is no neuroimaging test that can detect the interface astrocytic scar (IAS), which hinders the diagnosis, prevention, and treatment of repeated blast - induced brain injury (rBBI).
- IAS is a pathological feature in military personnel due to repeated blast exposures (RBE), but it can only be confirmed through autopsy.

2. **TSPO PET as a potential biomarker**:
- TSPO PET can detect neuroinflammation, which is considered an early signal before the occurrence of IAS.
- The research hopes to detect neuroinflammation at the gray - white matter junction through TSPO PET to identify individuals who may have IAS.

3. **Verify the effectiveness of TSPO PET**:
- By performing [11C]PBR28 TSPO PET scans on 27 active - duty members of the U.S. Special Operations Forces with a high cumulative blast - exposure level and comparing them with 9 healthy civilian volunteers, evaluate whether TSPO PET can effectively identify individuals with a significantly elevated TSPO signal.
- The research found that the TSPO signals of 5 operators were more than two standard deviations above the mean of the control group, accounting for 18.5% of the total sample.

### Research objectives:

- Verify whether TSPO PET can be used as a potential biomarker for detecting neuroinflammation and IAS that may occur after repeated blast exposures.
- Provide a basis for further research on TSPO PET as a diagnostic tool for rBBI.

### Conclusion:

Although the research results indicate that TSPO PET can detect neuroinflammation in some individuals, these observations still need further verification. Future research needs to explore more deeply the mechanism of TSPO signal changes and its relationship with repeated blast exposures to determine whether TSPO PET can be used as a reliable biomarker.